Inovio Pharmaceuticals Inc

NASDAQ:INO  
1.99
+0.24 (+13.43%)
Earnings Announcements

Inovio Reports Q1 Loss Per Share Of $0.36

Published: 05/10/2022 22:10 GMT
Inovio Pharmaceuticals Inc (INO) - Inovio Reports First Quarter 2022 Financial Results and Program Developments.
Q1 Loss per Share $0.36.
Q1 Revenue $199,000.
Q1 Earnings per Share View $-0.34, Revenue View $671670.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.63 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0.63 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.